KCNK16 and MODY: Both mouse and human islets expressing TALK-1 Leu114Pro exhibited significantly reduced glucose-stimulated insulin secretion compared to those expressing the wild-type, suggesting that KCNK16 May be a novel pathogenic gene for MODY [38].